Pyocyanin-Enhanced Neutrophil Extracellular Trap Formation Requires the NADPH Oxidase

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Rada, Balázs ^a,b   Jendrysik, Meghan A ^a   Pang, Lan ^b   Hayes, Craig P ^b   Yoo, Dae Goon ^b   Park, Jonathan J ^a   Moskowitz, Samuel M ^c,d   Malech, Harry L ^a   Leto, Thomas L ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P47; PYOCYANINE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE;

ARTICLE; BACTERIUM ISOLATE; CHRONIC GRANULOMATOUS DISEASE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NEUTROPHIL; NEUTROPHIL EXTRACELLULAR TRAP; NONHUMAN; PROTEIN DEFICIENCY; PROTEIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; TIME;

HUMANS; NADPH OXIDASE; NEUTROPHILS; PYOCYANINE; REACTIVE OXYGEN SPECIES;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84872342921     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0054205     Document Type: Article

References (48)

1. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, et al. (2004) Neutrophil extracellular traps kill bacteria. Science 303: 1532-1535.
2. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, et al. (2012) Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med. 18: 1386-93.
3. Fuchs TA, Abed U, Goosmann C, Hurwitz R, Schulze I, et al. (2007) Novel cell death program leads to neutrophil extracellular traps. J Cell Biol 176: 231-241.
4. Remijsen Q, Vanden Berghe T, Wirawan E, Asselbergh B, Parthoens E, et al. (2011) Neutrophil extracellular trap cell death requires both autophagy and superoxide generation. Cell Res 21: 290-304.
5. Wartha F, Beiter K, Normark S, Henriques-Normark B, (2007) Neutrophil extracellular traps: casting the NET over pathogenesis. Curr Opin Microbiol 10: 52-56.
6. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, et al. (2010) Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363: 2600-2610.
7. Logters T, Margraf S, Altrichter J, Cinatl J, Mitzner S, et al. (2009) The clinical value of neutrophil extracellular traps. Med Microbiol Immunol 198: 211-219.
8. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, et al. (2011) Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med 3: 73ra20.
9. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, et al. (2011) Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med 3: 73ra19.
10. Manzenreiter R, Kienberger F, Marcos V, Schilcher K, Krautgartner WD, et al. (2012) Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy. J Cyst Fibros. 11: 84-92.
11. Williams BJ, Dehnbostel J, Blackwell TS, (2010) Pseudomonas aeruginosa: host defence in lung diseases. Respirology 15: 1037-1056.
12. Stutts MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, et al. (1995) CFTR as a cAMP-dependent regulator of sodium channels. Science 269: 847-850.
13. Rowe SM, Miller S, Sorscher EJ, (2005) Cystic fibrosis. N Engl J Med 352: 1992-2001.
14. Hoiby N, (2011) Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med 9: 32.
15. Koh AY, Priebe GP, Ray C, Van Rooijen N, Pier GB, (2009) Inescapable need for neutrophils as mediators of cellular innate immunity to acute Pseudomonas aeruginosa pneumonia. Infect Immun 77: 5300-5310.
16. Lau GW, Hassett DJ, Ran H, Kong F, (2004) The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol Med 10: 599-606.
17. Fothergill JL, Panagea S, Hart CA, Walshaw MJ, Pitt TL, et al. (2007) Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain. BMC Microbiol 7: 45.
18. Wilson R, Sykes DA, Watson D, Rutman A, Taylor GW, et al. (1988) Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect Immun 56: 2515-2517.
19. Hunter RC, Klepac-Ceraj V, Lorenzi MM, Grotzinger H, Martin TR, et al. (2012) Phenazine Content in the Cystic Fibrosis Respiratory Tract Negatively Correlates with Lung Function and Microbial Complexity. Am J Respir Cell Mol Biol. 47: 738-45.
20. Lau GW, Ran H, Kong F, Hassett DJ, Mavrodi D, (2004) Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect Immun 72: 4275-4278.
21. Rada B, Gardina P, Myers TG, Leto TL, (2011) Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin. Mucosal Immunol 4: 158-171.
22. Rada B, Lekstrom K, Damian S, Dupuy C, Leto TL, (2008) The Pseudomonas toxin pyocyanin inhibits the dual oxidase-based antimicrobial system as it imposes oxidative stress on airway epithelial cells. J Immunol 181: 4883-4893.
23. Rada B, Leto TL, (2009) Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin. Immunol Res 43: 198-209.
24. Muller PK, Krohn K, Muhlradt PF, (1989) Effects of pyocyanine, a phenazine dye from Pseudomonas aeruginosa, on oxidative burst and bacterial killing in human neutrophils. Infect Immun 57: 2591-2596.
25. Usher LR, Lawson RA, Geary I, Taylor CJ, Bingle CD, et al. (2002) Induction of neutrophil apoptosis by the Pseudomonas aeruginosa exotoxin pyocyanin: a potential mechanism of persistent infection. J Immunol 168: 1861-1868.
26. Hoiby N, Ciofu O, Bjarnsholt T, (2010) Pseudomonas aeruginosa biofilms in cystic fibrosis. Future Microbiol 5: 1663-1674.
27. Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M, (2003) Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin Exp Rheumatol 21: S95-100.
28. Kim JS, Okamoto K, Rubin BK, (2006) Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Chest 129: 1148-1154.
29. Suri R, (2005) The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis. BioDrugs 19: 135-144.
30. Das T, Manefield M, (2012) Pyocyanin Promotes Extracellular DNA Release in Pseudomonas aeruginosa. PLoS One 7: e46718.
31. Wang Y, Li M, Stadler S, Correll S, Li P, et al. (2009) Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184: 205-213.
32. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, et al. (2010) PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 207: 1853-1862.
33. Leshner M, Wang S, Lewis C, Zheng H, Chen XA, et al. (2012) PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol 3: 307.
34. Hakkim A, Fuchs TA, Martinez NE, Hess S, Prinz H, et al. (2011) Activation of the Raf-MEK-ERK pathway is required for neutrophil extracellular trap formation. Nat Chem Biol 7: 75-77.
35. Marcos V, Zhou Z, Yildirim AO, Bohla A, Hector A, et al. (2010) CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med 16: 1018-1023.
36. Young RL, Malcolm KC, Kret JE, Caceres SM, Poch KR, et al. (2011) Neutrophil Extracellular Trap (NET)-Mediated Killing of Pseudomonas aeruginosa: Evidence of Acquired Resistance within the CF Airway, Independent of CFTR. PLoS One 6: e23637.
37. Liu GY, Nizet V, (2009) Color me bad: microbial pigments as virulence factors. Trends Microbiol 17: 406-413.
38. Hawkins PT, Stephens LR, Suire S, Wilson M, (2010) PI3K signaling in neutrophils. Curr Top Microbiol Immunol 346: 183-202.
39. Martelli AM, Evangelisti C, Chappell W, Abrams SL, Basecke J, et al. (2011) Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia 25: 1064-1079.
40. Huang J, Brumell JH, (2009) NADPH oxidases contribute to autophagy regulation. Autophagy 5: 887-889.
41. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, et al. (2009) Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci U S A 106: 6226-6231.
42. Wang Y, Newman DK, (2008) Redox reactions of phenazine antibiotics with ferric (hydr)oxides and molecular oxygen. Environ Sci Technol 42: 2380-2386.
43. Rada B, Leto TL, (2008) Oxidative innate immune defenses by Nox/Duox family NADPH oxidases. Contrib Microbiol 15: 164-187.
44. Ueyama T, Nakakita J, Nakamura T, Kobayashi T, Kobayashi T, et al. (2011) Cooperation of p40(phox) with p47(phox) for Nox2-based NADPH oxidase activation during Fcgamma receptor (FcgammaR)-mediated phagocytosis: mechanism for acquisition of p40(phox) phosphatidylinositol 3-phosphate (PI(3)P) binding. J Biol Chem 286: 40693-40705.
45. El Jamali A, Valente AJ, Clark RA, (2010) Regulation of phagocyte NADPH oxidase by hydrogen peroxide through a Ca(2+)/c-Abl signaling pathway. Free Radic Biol Med 48: 798-810.
46. Rada BK, Geiszt M, Kaldi K, Timar C, Ligeti E, (2004) Dual role of phagocytic NADPH oxidase in bacterial killing. Blood 104: 2947-2953.
47. Song E, Jaishankar GB, Saleh H, Jithpratuck W, Sahni R, et al. (2011) Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy 9: 10.
48. Brinkmann V, Laube B, Abu Abed U, Goosmann C, Zychlinsky A (2010) Neutrophil extracellular traps: how to generate and visualize them. J Vis Exp.